Skip NavigationSkip to Content

Rational approach to AIDS drug design through structural biology

  1. Author:
    Wlodawer, A.
  2. Author Address

    NCI, Macromol Crystallog Lab, Frederick, MD 21702 USA. NCI, Macromol Crystallog Lab, Frederick, MD 21702 USA. Wlodawer A NCI, Macromol Crystallog Lab, Frederick, MD 21702 USA.
    1. Year: 2002
  1. Journal: Annual Review of Medicine
    1. 53
    2. Pages: 595-614
  2. Type of Article: Review
  1. Abstract:

    The discovery and development of more than a dozen drugs in the past 15 years for the treatment of AIDS offer an excellent example of progress in the field of rational drug design. At this time, the principal targets are reverse transcriptase and protease, enzymes encoded by the human immunodeficiency virus. The introduction of protease inhibitors, in particular, has drastically decreased the mortality and morbidity associated with AIDS. This review presents the methods used to develop such drugs and discusses the remaining problems, such as the rapid emergence of drug resistance.

    See More

External Sources

  1. No sources found.

Library Notes

  1. No notes added.
NCI at Frederick

You are leaving a government website.

This external link provides additional information that is consistent with the intended purpose of this site. The government cannot attest to the accuracy of a non-federal site.

Linking to a non-federal site does not constitute an endorsement by this institution or any of its employees of the sponsors or the information and products presented on the site. You will be subject to the destination site's privacy policy when you follow the link.

ContinueCancel